IRIS UniCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.866
EU - Europa 5.257
AS - Asia 4.228
SA - Sud America 642
Continente sconosciuto - Info sul continente non disponibili 187
OC - Oceania 180
AF - Africa 140
Totale 18.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.573
DE - Germania 1.737
SG - Singapore 1.594
CN - Cina 1.284
IT - Italia 791
SE - Svezia 684
BR - Brasile 506
VN - Vietnam 430
FR - Francia 346
GB - Regno Unito 335
UA - Ucraina 298
PL - Polonia 270
IN - India 206
CA - Canada 189
FI - Finlandia 178
IE - Irlanda 160
AU - Australia 155
ID - Indonesia 116
BD - Bangladesh 96
JP - Giappone 85
TR - Turchia 74
RU - Federazione Russa 73
HK - Hong Kong 71
NL - Olanda 66
MX - Messico 54
AR - Argentina 41
AT - Austria 38
ES - Italia 38
ZA - Sudafrica 34
IQ - Iraq 33
CH - Svizzera 28
BE - Belgio 26
IR - Iran 26
PK - Pakistan 26
RO - Romania 26
KR - Corea 25
CI - Costa d'Avorio 23
NZ - Nuova Zelanda 23
CO - Colombia 21
CZ - Repubblica Ceca 20
EC - Ecuador 17
EG - Egitto 17
VE - Venezuela 17
GR - Grecia 16
IL - Israele 16
MY - Malesia 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
HU - Ungheria 15
DZ - Algeria 14
PT - Portogallo 13
BG - Bulgaria 12
CL - Cile 12
LT - Lituania 12
MA - Marocco 12
PY - Paraguay 12
UZ - Uzbekistan 11
KE - Kenya 10
NO - Norvegia 10
PH - Filippine 10
SK - Slovacchia (Repubblica Slovacca) 10
TH - Thailandia 10
DK - Danimarca 9
HN - Honduras 9
LB - Libano 9
HR - Croazia 7
JM - Giamaica 7
JO - Giordania 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
GE - Georgia 6
NP - Nepal 6
PE - Perù 6
RS - Serbia 6
TN - Tunisia 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
KG - Kirghizistan 5
LV - Lettonia 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
CG - Congo 4
MK - Macedonia 4
OM - Oman 4
PS - Palestinian Territory 4
SI - Slovenia 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
LY - Libia 3
ME - Montenegro 3
BB - Barbados 2
Totale 18.281
Salva come PNG Salva come JPEG
Città #
Singapore 938
Ashburn 655
Chandler 639
San Jose 464
Beijing 310
Jacksonville 223
Warsaw 222
Munich 193
Los Angeles 172
Houston 170
New York 160
Dublin 151
Nanjing 150
Dearborn 142
Milan 142
San Mateo 140
Woodbridge 133
Ann Arbor 132
Fairfield 131
Ho Chi Minh City 130
Rome 125
Hanoi 121
Wilmington 113
Hangzhou 105
Chicago 96
Nürnberg 95
Jakarta 94
Redwood City 93
Seattle 93
Helsinki 92
Dallas 90
The Dalles 86
Lauterbourg 83
Cambridge 76
Tokyo 69
Bremen 67
Hefei 67
Hong Kong 66
Boston 59
Nanchang 59
Frankfurt am Main 58
Council Bluffs 56
Orem 54
Cattolica 52
Lawrence 52
Moscow 52
Buffalo 49
São Paulo 48
Santa Clara 47
Brooklyn 45
San Francisco 42
London 41
Atlanta 38
Izmir 37
Marseille 37
Sydney 36
Guangzhou 35
Toronto 35
Kunming 33
Shanghai 33
Boardman 32
Denver 32
Phoenix 32
Portland 32
Lancaster 29
Haiphong 28
Melbourne 27
Montreal 26
Brisbane 24
Hyderabad 24
Shenyang 24
Abidjan 23
Chennai 23
Princeton 23
Adelaide 22
Tianjin 22
Brussels 21
Poplar 21
Johannesburg 20
Kent 20
Changsha 19
Da Nang 19
Leawood 19
Nuremberg 19
Amsterdam 18
Auburn Hills 18
Hebei 18
Mexico City 18
Redmond 18
Fremont 17
Jiaxing 17
Mumbai 17
Philadelphia 17
Naples 16
San Diego 16
Baghdad 15
Manchester 15
Mountain View 15
University Park 15
Zhengzhou 15
Totale 8.872
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.742
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 434
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 354
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 330
DNMT1-interacting RNAs block gene-specific DNA methylation 294
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 288
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 283
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 271
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 245
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 244
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 243
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 243
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 238
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 237
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 237
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 224
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 218
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 204
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 200
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 194
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 193
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 193
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 193
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 192
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 192
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 190
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 188
Epigenetic changes in therapy-related MDS/AML 187
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 187
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 184
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 182
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 180
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 177
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 177
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 177
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 176
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 173
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 172
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Aggiornamenti di Diagnostica Molecolare in Ematologia 161
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 160
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 158
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 158
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 158
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 156
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 156
PU.1 and CEBPA expression in acute myeloid leukemia. 156
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 155
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 155
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 153
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 152
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 151
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 149
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 148
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 148
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 148
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 145
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 145
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 143
Outcome of therapy-related myeloid neoplasms treated with azacitidine 142
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 142
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 141
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 140
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 138
Mantle cell lymphoma relapsing at the lymphedematous arm 138
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 137
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 136
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 134
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 131
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 129
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 125
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 122
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 122
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 120
CAR-T Cell Therapy for Follicular Lymphomas 111
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 109
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 106
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 91
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 88
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study 88
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 83
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 81
Case of metastatic melanoma in bone marrow smear 79
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 78
Absence of structural mutations of the BAK gene in B cell lymphomas 77
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 39
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 32
Persistence of molecular remission throughout pregnancy in CML after imatinib 2
Totale 18.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022768 0 80 13 31 65 36 26 133 51 70 122 141
2022/20231.867 259 261 128 319 114 216 95 141 175 39 74 46
2023/20241.669 54 256 71 92 114 193 81 109 81 151 226 241
2024/20252.804 297 204 269 144 224 113 210 149 325 224 357 288
2025/20265.701 646 223 268 489 892 336 981 364 426 367 301 408
2026/2027328 285 43 0 0 0 0 0 0 0 0 0 0
Totale 18.500